Publications

CendR Platform™ Technology

Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model

Nature Communications: Tumor-penetrating therapy for ß5 integrin-rich pancreas cancer

Molecular Cancer Therapeutics: iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer

Cancer Research: Nanoparticles That Reshape the Tumor Milieu Create a Therapeutic Window for Effective T-cell Therapy in Solid Malignancies

Advanced Drug Delivery Reviews: Tumor penetrating peptides for improved drug delivery 

Nature Communications: In vivo cation exchange in quantum dots for tumor-specific imaging

Cancer Research: Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma 

British Journal of Cancer: Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1 

Science: Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs 

Show More

CD34+ Cell Technology

Clinical Practice Variations in the Management of Ischemia With No Obstructive Coronary Artery Disease

Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction

Transplantation of CD34+ cells for myocardial ischemia

Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair—A Systematic Review

Testing for Coronary Microvascular Dysfunction

Japan’s Conditional Approval Pathway for Regenerative Medicines

Show More

Related Cardiovascular Publications

Contemporary Management of Refractory Angina

Definition and epidemiology of coronary microvascular disease

Gender-Related Differences in Chest Pain Syndromes in the Frontiers in CV Medicine Special Issue: Sex & Gender in CV Medicine

Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis

Pathophysiology of Coronary Microvascular Dysfunction

Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases

Patient Perspective: Maria George founder of INOCA International

Treatment of coronary microvascular dysfunction

Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological Technologies.

Stem Cells in the Treatment of Disease

The Impact of Cell Therapy on Cardiovascular Outcomes in Patients With Refractory Angina

Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review

Treatment of angina and microvascular coronary dysfunction

Show More

Commentary

CEND-1: a game changer for pancreatic cancer chemotherapy?

Guest Commentary: Building a Problem or a Solution?

Agency Meetings with the US Food and Drug Administration